Paris, France

Thierry Poynard

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 1.0

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by Thierry Poynard

Introduction

Thierry Poynard is a notable inventor based in Paris, France. He has made significant contributions to the field of medical diagnostics, particularly concerning liver diseases. With a total of seven patents to his name, Poynard's work focuses on improving the prognosis and diagnosis of liver-related conditions.

Latest Patents

Among his latest patents is a method for prognosis and follow-up of primary liver cancer. This invention relates to new methods for assessing the risk of a patient, especially those with chronic liver disease, to develop primary liver cancer over time. It utilizes functions that combine blood biochemical markers for more accurate assessments. Another significant patent is a method for diagnosing drug-induced liver injury (DILI). This invention introduces new methods for assessing the prognosis of recovery from DILI in a patient, combining the measurement of serum markers through a logistic function that excludes bilirubin and transaminases (AST and ALT) markers.

Career Highlights

Throughout his career, Thierry Poynard has worked with prominent institutions, including Assistance Publique - Hôpitaux de Paris and Biopredictive. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Thierry Poynard's contributions to medical diagnostics, particularly in liver disease, highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to advancing medical technology and enhancing the accuracy of diagnoses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…